Illuminating biological pathways for drug targeting in head and neck squamous cell carcinoma

Head and neck squamous cell carcinoma (HNSCC) remains a morbid disease with poor prognosis and treatment that typically leaves patients with permanent damage to critical functions such as eating and talking. Currently only three targeted therapies are FDA approved for use in HNSCC, two of which are...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:PLoS One
Prif Awduron: Choonoo, Gabrielle, Blucher, Aurora S., Higgins, Samuel, Boardman, Mitzi, Jeng, Sophia, Zheng, Christina, Jacobs, James, Anderson, Ashley, Chamberlin, Steven, Evans, Nathaniel, Vigoda, Myles, Cordier, Benjamin, Tyner, Jeffrey W., Kulesz-Martin, Molly, McWeeney, Shannon K., Laderas, Ted
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Public Library of Science 2019
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6785123/
https://ncbi.nlm.nih.gov/pubmed/31596908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0223639
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg